Related Experiment Video
Updated: Oct 5, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Sequential modeling for a class of reference-based imputation methods in clinical trials with quantitative or binary
1AbbVie Inc., North Chicago, Illinois, USA.
This study introduces new reference-based imputation methods for analyzing clinical trial data with missing outcomes. These methods offer a broader approach to sensitivity analysis for missing not at random data.
Area of Science:
- Biostatistics
- Clinical Trials
- Epidemiology
Background:
- Missing data in longitudinal clinical trials complicates treatment effect estimation.
- Standard methods often assume data are missing at random, necessitating sensitivity analyses for missing not at random scenarios.
- Existing reference-based imputation methods like Jump to Reference (J2R) and Copy Reference (CR) have limitations.
Purpose of the Study:
- To propose a novel, comprehensive framework of reference-based imputation methods for sensitivity analysis in clinical trials.
- To extend existing methods by considering a spectrum of potential treatment carry-over effects after treatment deviation.
- To provide a flexible approach applicable to both quantitative and categorical longitudinal outcomes.
Main Methods:
- Developed a wide class of reference-based imputation methods, encompassing J2R and CR as boundary cases.
- The framework models the potential carried-over effect of an investigative treatment after deviation.
- Demonstrated implementation through sequential modeling, suitable for diverse outcome types.
Main Results:
- The proposed methods provide a unified framework for sensitivity analysis.
- The sequential modeling approach allows for practical application in various clinical trial settings.
- Causal-inference arguments and numerical examples validate the performance of the new methods.
Conclusions:
- The novel reference-based imputation methods offer a robust approach to handling missing data in longitudinal clinical trials.
- This framework enhances the reliability of treatment effect estimation under missing not at random assumptions.
- The methods are versatile, applicable to both quantitative and categorical outcomes, and implementable via sequential modeling.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Statistical Software for Data Analysis and Clinical Trials
Assumptions of Survival Analysis

